Heart Disease News and Research

Latest Heart Disease News and Research

IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treatment

IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.

28 Oct 2010

Teck donates $2.5M to support emergency programs and services at St. Paul's Hospital

St. Paul's Hospital Foundation today announced that Teck Resources Limited donated $2.5 million to St. Paul's Hospital to complete the remaining funding for its recently renovated and redesigned emergency area. In recognition of Teck's major gift, the area will be named the Teck Emergency Centre. Furthermore, a fund to support research, academic productivity and the development of best practices at the hospital will be called the Teck Emergency Centre Innovation Fund.

28 Oct 2010

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants including those renowned for their apparent ability to prevent cancer may actually aggravate or even cause cancer in some individuals.

28 Oct 2010

Mirada Medical and Moffitt Cancer Center enter joint development agreement

Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced today that they have signed an agreement with Moffitt Cancer Center, Tampa, FL, one of the USA's top centers for cancer treatment and oncology research.

28 Oct 2010

Systemic amyloidosis patient to receive triple organ transplant

In 2005, then 40-year-old Walt McGuire was playing hockey twice a week, working full-time and chasing his young daughter. Then one day, he noticed after one trip up the stairs to catch her, he couldn't catch his breath. A few days later his legs were swollen. After numerous trips to different doctors, McGuire finally was diagnosed with a rare blood disorder called amyloidosis.

28 Oct 2010

Abbott provides $180,000 to support recent cholera outbreak in central Haiti

Abbott is providing $180,000 in support to help address the recent cholera outbreak in central Haiti. This includes a $25,000 grant from the Abbott Fund to Partners In Health, and $155,000 in donated Abbott rehydration solutions and antibiotics.

28 Oct 2010

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

The Methodist Hospital Research Institute® (TMHRI) today opened a 12-story, 440,000 square foot research facility dedicated solely to research and equipped with the world's most advanced technology to help research scientists, physicians and engineers cure diseases that afflict today's patients.

28 Oct 2010

1000 Genomes Project publishes comprehensive map of genetic variations in Nature journal

Small genetic differences between individuals help explain why some people have a higher risk than others for developing illnesses such as diabetes or cancer. Today in the journal Nature, the 1000 Genomes Project, an international public-private consortium, published the most comprehensive map of these genetic differences, called variations, estimated to contain approximately 95 percent of the genetic variation of any person on Earth.

28 Oct 2010

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumors, today announced the initiation of the first clinical study to evaluate the use of the Calypso System for tracking lung cancer tumors during radiation delivery, including a new design of the Company's implantable Beacon transponder.

28 Oct 2010

New national campaign to drive awareness on DVT and PE prevention in women

As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.

28 Oct 2010

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.

28 Oct 2010

IBI receives U.S. patent for novel blood protein biomarkers

Intrinsic Bioprobes today announced that the United States Patents and Trademark Office has issued US Patent 7,816,095 covering novel blood protein biomarkers related to cardiovascular disease. This patent is first of a series of patent applications that cover specific human protein variants as biomarkers with clinical utility.

28 Oct 2010

deCODE genetics publishes high resolution recombination map of human genome in Nature journal

Scientists from deCODE genetics today publish in Nature the highest resolution recombination map of the human genome yet developed. Recombination is the reshuffling of the genome that occurs in the formation of eggs and sperm: we inherit one version of each chromosome from each of our parents, and create novel blends of the two that we pass on to our offspring.

28 Oct 2010

Glaxo to pay $750 million settlement for defective, unsafe medicines

The New York Times: "GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines." The 20 medicines that were produced with "questionable safety" measures included "Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet an acid reflux drug."

28 Oct 2010

HRS to co-sponsor world's premier annual electrophysiology meeting

The North American Center for Continuing Medical Education, LLC in partnership with HMP Communications, LLC, publisher of EP Lab Digest, today announced that the Electrophysiology Innovations Congress--EP Innovations 2010 will be co-sponsored by the Heart Rhythm Society. Electrophysiology Innovations Congress EP Innovations 2010, the world's premier annual electrophysiology meeting, will take place December 9-11, 2010, at the Washington Hilton in Washington, DC.

27 Oct 2010

DMC and Vanguard extend definitive purchase agreement

The DMC Board voted this afternoon to extend their definitive purchase agreement with Vanguard Health Systems through the end of the year, allowing more time to complete governmental approvals. Vanguard's purchase of – and $850 million capital investment in – the Detroit Medical Center is the single largest private investment in Detroit's history.

27 Oct 2010

AseraCare publishes guide book on hospice

AseraCare Hospice, one of the nation's premier providers of hospice and palliative care services, has published Hospice: The Loving Circle of Care, a book that guides readers through the difficult process of deciding when to seek hospice. Hospice: The Loving Circle of Care helps hospice patients and their families as well as physicians and caregivers understand hospice and its benefits, while providing personal accounts of AseraCare patient experiences.

27 Oct 2010

Preventive health programs reduce employee health risks

With employers and individuals continuing to struggle with rising health care costs, a new study shows there is one strategy that is proven to slow the pace of this ever increasing burden: preventive health. Published today in Population Health Management, "The Impact of The Prevention Plan on Employee Health Risk Reduction" reveals that prevention programs based on the clinical practice of preventive medicine are able to achieve measurable health risk reduction in just one year.

27 Oct 2010

MedAvante's centralized ratings to be used in Rexahn's Serdaxin Phase 2a study in MDD patients

MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that Rexahn will use MedAvante 's Remote Centralized Ratings™ in their randomized, double-blind, placebo-controlled Phase 2b clinical study assessing the efficacy of Serdaxin® in patients with major depressive disorder (MDD).

27 Oct 2010

Two-thirds of fetuses with HLHS have strong chance of survival

When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis. In HLHS, one of the heart's pumping chambers is severely underdeveloped. However, say researchers, in two-thirds of cases, reconstructive surgery affords the infant an excellent chance of early survival.

27 Oct 2010

Heart Disease News and Research

Latest Heart Disease News and Research

IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treatment

Teck donates $2.5M to support emergency programs and services at St. Paul's Hospital

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Mirada Medical and Moffitt Cancer Center enter joint development agreement

Systemic amyloidosis patient to receive triple organ transplant

Abbott provides $180,000 to support recent cholera outbreak in central Haiti

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

1000 Genomes Project publishes comprehensive map of genetic variations in Nature journal

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

New national campaign to drive awareness on DVT and PE prevention in women

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

IBI receives U.S. patent for novel blood protein biomarkers

deCODE genetics publishes high resolution recombination map of human genome in Nature journal

Glaxo to pay $750 million settlement for defective, unsafe medicines

HRS to co-sponsor world's premier annual electrophysiology meeting

DMC and Vanguard extend definitive purchase agreement

AseraCare publishes guide book on hospice

Preventive health programs reduce employee health risks

MedAvante's centralized ratings to be used in Rexahn's Serdaxin Phase 2a study in MDD patients

Two-thirds of fetuses with HLHS have strong chance of survival

Forensics and toxicology - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Forensics and toxicology - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in